PHENOXYBENZAMINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Phenoxybenzamine Hydrochloride, and what generic alternatives are available?
Phenoxybenzamine Hydrochloride is a drug marketed by Amneal, Aurobindo Pharma, Hikma, Novitium Pharma, Par Pharm Inc, and Rising. and is included in six NDAs.
The generic ingredient in PHENOXYBENZAMINE HYDROCHLORIDE is phenoxybenzamine hydrochloride. There are seven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the phenoxybenzamine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Phenoxybenzamine Hydrochloride
A generic version of PHENOXYBENZAMINE HYDROCHLORIDE was approved as phenoxybenzamine hydrochloride by PAR PHARM INC on January 24th, 2017.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PHENOXYBENZAMINE HYDROCHLORIDE?
- What are the global sales for PHENOXYBENZAMINE HYDROCHLORIDE?
- What is Average Wholesale Price for PHENOXYBENZAMINE HYDROCHLORIDE?
Summary for PHENOXYBENZAMINE HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 6 |
NDAs: | 6 |
Finished Product Suppliers / Packagers: | 5 |
Raw Ingredient (Bulk) Api Vendors: | 104 |
Clinical Trials: | 7 |
Patent Applications: | 637 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in PHENOXYBENZAMINE HYDROCHLORIDE? | PHENOXYBENZAMINE HYDROCHLORIDE excipients list |
DailyMed Link: | PHENOXYBENZAMINE HYDROCHLORIDE at DailyMed |
![PHENOXYBENZAMINE HYDROCHLORIDE drug patent expirations Drug patent expirations by year for PHENOXYBENZAMINE HYDROCHLORIDE](/p/graph/s/t/PHENOXYBENZAMINE_HYDROCHLORIDE-patent-expirations.png)
Recent Clinical Trials for PHENOXYBENZAMINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Seoul National University Hospital | Phase 4 |
University of California, Los Angeles | Phase 3 |
Erasmus Medical Center | Phase 4 |
Pharmacology for PHENOXYBENZAMINE HYDROCHLORIDE
Drug Class | alpha-Adrenergic Blocker |
Mechanism of Action | Adrenergic alpha-Antagonists |
Medical Subject Heading (MeSH) Categories for PHENOXYBENZAMINE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for PHENOXYBENZAMINE HYDROCHLORIDE
US Patents and Regulatory Information for PHENOXYBENZAMINE HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amneal | PHENOXYBENZAMINE HYDROCHLORIDE | phenoxybenzamine hydrochloride | CAPSULE;ORAL | 212568-001 | Oct 27, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Novitium Pharma | PHENOXYBENZAMINE HYDROCHLORIDE | phenoxybenzamine hydrochloride | CAPSULE;ORAL | 215042-001 | Jul 19, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Aurobindo Pharma | PHENOXYBENZAMINE HYDROCHLORIDE | phenoxybenzamine hydrochloride | CAPSULE;ORAL | 215600-001 | May 8, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Hikma | PHENOXYBENZAMINE HYDROCHLORIDE | phenoxybenzamine hydrochloride | CAPSULE;ORAL | 201050-001 | Jul 16, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |